Discover
TCRT
Alaunos Therapeutics, Inc.
2.63
1 x 2.16
1 x 2.90
bid
ask
+
0.45
20.64%
1 @ 04:34 PM
2.72 +0.09 (3.42%)
| Ytd | -18.58% | |
| 1y | -15.16% |
2.31
day range
2.99
0.72
52 week range
4.50
| Open | 2.81 | Prev Close | 2.18 | Low | 2.31 | High | 2.99 | Mkt Cap | 7.70M |
| Vol | 31.60M | Avg Vol | 6.18M | EPS | -1.76 | P/E | N/A | Forward P/E | -3.25 |
| Beta | -0.50 | Short Ratio | 10.12 | Inst. Own | 12.08% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-14 | 50-d Avg | 1.52 | 200-d Avg | 2.37 | 1yr Est | 1.75 |
| Income Statement | |||
| Operating Expenses | 952.00K | ||
| Research and Development Expense | 388.00K | ||
| Selling, General and Administrative Expense | 564.00K | ||
| Operating Income | -952.00K | ||
| Net Income | -952.00K | ||
| Net Income Common Stock | -952.00K | ||
| Net Income Common Stock (USD) | -952.00K | ||
| Consolidated Income | -952.00K | ||
| Earnings per Basic Share | -0.41 | ||
| Earnings per Basic Share (USD) | -0.41 | ||
| Earnings per Diluted Share | -0.41 | ||
| Earning Before Interest & Taxes (EBIT) | -952.00K | ||
| Earning Before Interest & Taxes (USD) | -952.00K | ||
| Weighted Average Shares | 2.43M | ||
| Weighted Average Shares Diluted | 2.43M | ||
| Balance Sheet | |||
| Cash and Equivalents | 124.00K | ||
| Cash and Equivalents (USD) | 124.00K | ||
| Current Assets | 666.00K | ||
| Property, Plant & Equipment Net | 74.00K | ||
| Total Assets | 1.52M | ||
| Current Liabilities | 864.00K | ||
| Total Liabilities | 864.00K | ||
| Accumulated Retained Earnings (Deficit) | -926.58M | ||
| Shareholders Equity | 652.00K | ||
| Shareholders Equity (USD) | 652.00K | ||
| Assets Non-Current | 850.00K | ||
| Trade and Non-Trade Payables | 732.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 9.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -230.00K | ||
| Net Cash Flow from Operations | -300.00K | ||
| Share Based Compensation | -28.00K | ||